Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

New effective scar treatments are urgently needed due to the current options' limited success.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Turning scar-forming cells into fat cells can reduce scarring.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

ECM-inspired wound dressings can help heal chronic wounds by controlling macrophage activity.

Transplanting hair follicles into chronic ulcers helps them heal better.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.